Evidence map›Paper›PMID 39630767›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2024

Associations of the atherogenic index of plasma with insulin resistance and inflammation.

Yasin Altun, Halime Dilber Balcı, Nilay Çom Aybal

Abstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yasin AltunNiğde Omer Halisdemir University, Faculty of Medicine, Department of Family Medicine - Niğde, Turkey.ORCID http://orcid.org/0000-0002-1521-4349
Halime Dilber BalcıNiğde Omer Halisdemir University Research and Training Hospital - Niğde, Turkey.ORCID http://orcid.org/0000-0003-0154-8046
Nilay Çom AybalYalova University, Faculty of Medicine, Department of Family Medicine - Yalova, Turkey.ORCID http://orcid.org/0000-0003-3458-2523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to investigate the association between the atherogenic index of plasma and insulin resistance, while also evaluating atherogenic index of plasma's prognostic value in inflammation by examining its correlation with platelet/lymphocyte ratio and neutrophil/lymphocyte ratio.

methodsData collection involved accessing records from January 2022 to December 2022, with analyses including calculation of atherogenic index of plasma and homeostatic model assessment index.

resultsData from 510 patients (mean age: 48.90±18.71 years; 69.4% female) showed a mean atherogenic index of plasma of 0.40±0.28, with 69% at high risk. Significant positive correlations were found between atherogenic index of plasma and age, lymphocyte, neutrophil, C-reactive protein, glucose, insulin, and homeostatic model assessment-insulin resistance, while the correlation with platelet/lymphocyte ratio was significantly negative.

conclusionAtherogenic index of plasma presents as a promising predictor for insulin resistance, demonstrating robust associations with inflammation, thus offering valuable clinical insights and potential for early risk assessment and management strategies.

Indexed as

AtherosclerosisC-Reactive ProteinInflammationInsulin ResistanceAdultAgedBiomarkersBlood GlucoseFemaleHumansLymphocyte CountLymphocytesMaleMiddle AgedNeutrophilsPlatelet CountBiomarkersBlood GlucoseC-Reactive Protein

Identifiers

PMID39630767
PMCPMC11639574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.